BioSpace News Archive

Sage Therapeutics announced that, on February 1, 2019, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 8,500 shares of its common stock, and 750 performance restricted stock units to two new employees under Sage’s 2016 Inducement Equity Plan.

Smart Data Solutions, a MN based collateral-processing and workflow automation service, is pleased to announce and welcome Chris Mueller as the Clearinghouse Business Development Director.

Pharmazz, Inc. announced that data from the Phase 2 clinical study in patients with acute cerebral ischemic stroke, were presented in the late breaking Multicenter, Ongoing Clinical Trials Posters II session at the International Stroke Conference 2019 in Honolulu, Hawaii February 6-8, 2019.

Covetrus, Inc. announced that its common stock has been approved for listing on the Nasdaq Global Select Market and, on February 4, 2019, began trading on a “when-issued” basis under the trading symbol “CVETV.”

Honor is Firm’s fifth in this category providing strong start to 2019

Marker Therapeutics, Inc. announced the appointment of Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development.

Strong interim survival trend (15.2 vs 8.5 months) emerging in IL4R positive patients

STAAR Surgical Company announced that it will release financial results for the fourth quarter and fiscal year ended December 28, 2018 on Thursday, February 21, 2019 after the market close.

Spectrum Pharmaceuticals announced that an overview of the company’s business strategy and development-stage programs will be given at the Guggenheim Healthcare Talks Idea Forum | Oncology Day being held in New York.

Deciphera Pharmaceuticals, Inc. announced that Michael Taylor, Ph.D., President and Chief Executive Officer, will present at the 1st Annual Guggenheim Healthcare Talks Idea Forum Oncology Day on Thursday, February 14 at 3:30 PM ET at the St.